Image de couverture de livre

Effectiveness and Safety of Setmelanotide in a Patient With a Heterozygous PCSK1 Deficiency

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Ellina Lytvyak, Arshdeep Rattol, Eduardo Grunvald
Format:	Artículo Open Access
Publié:	Wiley 2026
Sujets:	Obesity
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Setmelanotide in Bardet‐Biedl Syndrome: A 52‐Week Comparison of Phase 3 Trial Participants With a Matched Registry Cohort
par: Jesús Argente, et autres
Publié: (2026)

Correction to “Setmelanotide in Bardet‐Biedl Syndrome: A 52‐Week Comparison of Phase 3 Trial Participants With a Matched Registry Cohort”
Publié: (2026)

Treatment Approaches for Obesity in Children With Heterozygous MC4R Variants
par: Mostafa Salama, et autres
Publié: (2026)

Micronutrient and Nutritional Deficiencies Associated With GLP ‐1 Receptor Agonist Therapy: A Narrative Review
par: Jorge Urbina, et autres
Publié: (2026)

Effectiveness and Safety of Finerenone in Patients With Diabetic Kidney Disease: A Real‐World Observational Study
par: Jaehyun Bae, et autres
Publié: (2026)

Effectiveness and Safety of Evogliptin in Patients With Type 2 Diabetes Mellitus: A Multicenter, Prospective, Observational Study
par: Jun Hwa Hong, et autres
Publié: (2026)

Safety and Cost‐Effectiveness of Early Discharge Following Bariatric Surgery in an Underserved Urban Population
par: Dimitri Chepkunov, et autres
Publié: (2026)

Mindful eating and its relationship with body mass index, binge eating, anxiety and negative affect
par: Sheila Pintado-Cucarella
Publié: (2016)

DNAJB3 Deficiency in Mice, Sex‐Dependently, Exacerbates High‐Fat Diet‐Induced Metabolic Dysfunctions
par: Shadi Nejat, et autres
Publié: (2025)

Nutritional Deficiencies Following Bariatric Surgery: A Rapid Systematic Review of Case Reports of Vitamin and Micronutrient Deficiencies Presenting More Than Two Years Post‐Surgery
par: Sophie Haughton, et autres
Publié: (2025)

Efficacy and Safety of Tirzepatide in Japanese Participants With Obesity: A Subpopulation Analysis of the SURMOUNT ‐1 Trial
par: Yasushi Ishigaki, et autres
Publié: (2026)

Cost‐Effectiveness of Two Iterations of a Community‐Based Cardiovascular Disease Prevention Intervention
par: Elena Andreyeva, et autres
Publié: (2025)

Efficacy and Safety of Tirzepatide on Weight Loss in Patients Without Diabetes Mellitus: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
par: Sharath Kommu, et autres
Publié: (2025)

Genetic Risk Scores for Obesity and the Effectiveness of a Diet and Exercise Intervention Program: A Historical Cohort Study
par: Sho Nakamura, et autres
Publié: (2025)

Efficacy and Safety of GLP ‐1 Receptor Agonists, Dual Agonists, and Retatrutide for Weight Loss in Adults With Overweight or Obesity: A Bayesian NMA
par: Binayak Sinha, et autres
Publié: (2025)

Understanding the Increasing Prevalence of Obesity in Patients With Type 1 Diabetes: Strategies for Improving Clinical Care
par: Kathleen R. Ruddiman, et autres
Publié: (2025)

Effectiveness of Telemedicine Prescribing and a Long‐Acting Obesity Medication Behavioral Program: A 24‐Week Single‐Arm Study
par: Leslie J. Heinberg, et autres
Publié: (2025)

Effects of a 2‐Year Primary Care Weight Loss Intervention on Quality of Life in Patients With Obesity
par: Kara D. Denstel, et autres
Publié: (2026)

Six‐Month Real‐World Effectiveness, Persistence and Safety of Low‐to‐Moderate Dose Tirzepatide in Adults With Obesity: A Multicentre Observational Study
par: Nikolaos Angelopoulos, et autres
Publié: (2026)

Cost‐Effectiveness of Control‐ IQ + Technology in Insulin‐Treated Patients With Type 2 Diabetes in the United States
par: Neda Al Rawashdh, et autres
Publié: (2026)

Psychiatric Safety of Tirzepatide in People With Obesity and No Known Major Psychopathology: A Post Hoc Analysis of SURMOUNT
par: Thomas A. Wadden, et autres
Publié: (2026)

Enfoque de la obesidad infantil desde la pediatría
par: Erika F. Hurtado-López
Publié: (2014)

EffectS of Lifestyle Interventions in Older PEople With Obesity (Effective SLOPE): a Systematic Review With Network Meta‐Analyses
par: Gabriel Torbahn, et autres
Publié: (2026)

Real‐World Weight‐Loss Outcomes in Weight‐Reduced Patients Treated With Tirzepatide
par: Sarah R. Barenbaum, et autres
Publié: (2026)

Semaglutide vs. Bariatric Surgery: Comparing Costs and Clinical Outcomes in Patients With Diabetes and Obesity
par: Karan R. Chhabra, et autres
Publié: (2026)

Emotion‐Related Treatments in Patients With Binge Eating Episodes—a Systematic Review and Meta‐Analysis
par: Kathrin Schag, et autres
Publié: (2025)

Dapagliflozin‐Associated Reduction in Liver Fat Is Independent of Weight Loss in Patients With Type 2 Diabetes
par: Anna V. Naumova, et autres
Publié: (2026)

Effectiveness and predictors of weight loss response to phentermine plus lifestyle modifications among youth in a paediatric weight management clinical setting
par: Eric M. Bomberg, et autres
Publié: (2024)

Patient and professional perceptions for long‐term success: Developing a framework for bariatric surgery care in Portugal
par: Cláudia Mendes, et autres
Publié: (2025)

Safety and efficacy of glucagon‐like peptide‐1 (GLP‐1) receptor agonists in patients with weight regain or insufficient weight loss after metabolic bariatric surgery: A systematic review and meta‐analysis
par: Ali Esparham, et autres
Publié: (2024)

Does the Combination of Abdominal Obesity and Vitamin D Deficiency Increase the Risk of Death in Individuals Aged 50 or Older? Evidence From the ELSA Study
par: Joyce da Silva Milliati, et autres
Publié: (2026)

Virtual Weight Management and Continuous Glucose Monitoring in Patients With Type 2 Diabetes: A Randomized Controlled Trial
par: Peter T. Katzmarzyk, et autres
Publié: (2026)

Class III Obesity as a Presenting Syndrome in Prolactinoma Patients: Insights Into Obesity and Metabolic Dysfunction in This Unique Group
par: Lukas Andereggen, et autres
Publié: (2026)

Safety, pharmacokinetics and pharmacodynamics of multiple‐dose noiiglutide ( SHR20004 ), a novel GLP ‐1 receptor agonist, in Chinese obese subjects without diabetes mellitus
par: Yang Zou, et autres
Publié: (2024)

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Petrelintide for Weight Management: Two Randomized, Controlled Phase 1 Trials
par: Minna Brændholt Olsen, et autres
Publié: (2026)

Grandmaternal Obesity and Risks of Birth Asphyxia‐Related Complications in Grand‐Offspring: A Countrywide Three‐Generation Study
par: Eduardo Villamor, et autres
Publié: (2025)

Role of Acid‐Sensing Ion Channels 1a in the Regulation of Obesity and the Gut Microbiota
par: Jane Shearer, et autres
Publié: (2025)

Glucagon‐like peptide 1 ( GLP ‐1) receptor agonists' use during pregnancy: Safety data from regulatory clinical trials
par: Claire H. Parker, et autres
Publié: (2025)

Less frequent dosing of GLP‐1 receptor agonists as a viable weight maintenance strategy
par: Calvin C. Wu, et autres
Publié: (2025)

Glucagon‐like peptide‐1 receptor agonists and upper endoscopy: a real‐world experience
par: Pichamol Jirapinyo, et autres
Publié: (2025)